Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Risk Mitigation Strategies for Pre-filled Syringe Systems

US FDA Guidance defines the criteria for extractable and leachable testing of container closure packaging components of pre-filled syringe systems; by adopting strategies, such as the use of a barrier film on syringe plungers and ready-to-sterilise components, the risk of such contamination can be mitigated.

Frances L DeGrazio, West Pharmaceutical Services, Inc (September 2010)

Keywords: US FDA Guidance extractable leachable testing container closure packaging components pre-filled syringe systems strategies barrier film syringe plungers sterilise components contamination mitigated

    View full article    |    Back to Ingredients, Formulations and Finishing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |